Survey/Biobank: National FinHealth 2017 Study (Finland): Difference between revisions

From Beacon
No edit summary
No edit summary
Line 8: Line 8:
'''Sponsor, manager or home institution:''' [[dataOwner::THL Biobank]].
'''Sponsor, manager or home institution:''' [[dataOwner::THL Biobank]].


'''Type of information:''' [[databaseStructure::cross-sectional]]. [[hasDataDictionary::Data Dictionary: National FinHealth 2017 Study]]. [https://thl.fi/tutkimus-ja-kehittaminen/tutkimukset-ja-hankkeet/kansallinen-finterveys-tutkimus/tutkimuslomakkeet/finterveys-2017-seuranta Click here to learn more].
'''Type of information:''' [[databaseStructure::longitudinal]]. [[hasDataDictionary::Data Dictionary: National FinHealth 2017 Study]]. [https://thl.fi/tutkimus-ja-kehittaminen/tutkimukset-ja-hankkeet/kansallinen-finterveys-tutkimus/tutkimuslomakkeet/finterveys-2017-seuranta Click here to learn more].


'''Data level:''' [[dataLevel::patient level]].
'''Data level:''' [[dataLevel::patient level]].

Revision as of 14:09, 5 June 2024

Go back to Finland page

Type of database: survey; biobank; genomics.

Primary purpose: Store the sample collection and data information of participants from the National FinHealth 2017 Study survey. The purpose of the survey was to produce up-to-date information on health, health behavior, functional capacity and well-being of adults.

Sponsor, manager or home institution: THL Biobank.

Type of information: longitudinal. Data Dictionary: National FinHealth 2017 Study. Click here to learn more.

Data level: patient level.

Number of records: 7.050 participants. Click here to learn more about study methods.

Date range: 2017 - 2021.

Cancer areas of interest: C00-D48: All neoplasms. Click here to learn more.

Data access: partially publicly available. Click here to access. Instructions to request data for restricted content click here to access.

Contact information: Click here to access.